RECENT HEALTHCARE DEVELOPMENTS
Recent policies reflect China’s goal of promoting patients’ access to innovative drugs. Noteworthy policy items include:
- The 2018 version of the Essential Drug List (EDL) was approved
- National Reimbursement Drug List (NRDL) Negotiation Results Released
- NMPA released List of Medical Devices Exempted from Clinical Trials
- Zhang Mao was appointed as Party Secretary of the SAMR
- NHC released Guiding Principles for Clinical Use of New Anti-Cancer Drugs (2018 Version)
Download the latest Issue Here >>